208 Nutritional intervention among children with CF  by Katseni, V. et al.
S100 10. Gastroenterology/Liver disease/Metabolic complications of CF/Nutrition/Growth Posters
208 Nutritional intervention among children with CF
V. Katseni1, E. Hatziagorou2, D. Lamboudis1, A. Kampouras2, T. Karagiozoglou-
Lampoudi1, J.N. Tsanakas2. 1Technological Education Institute, Dept of Nutrition/
Dietetics, School of Food Technology and Nutrition, Thessaloniki, Greece;
2Aristotle University of Thessaloniki, Hippokration Hospital, 3rd Paediatric Dept,
Thessaloniki, Greece
Objectives: To assess the effect of a six months’ implementation of a nutritional
intervention protocol on nutritional status in patients with cystic ﬁbrosis.
Methods: Nutritional status of 77 patients with CF (53.2% males, mean age
10.73±6.67 years, was evaluated. Anthropometry was expressed as z-scores for
age and sex using WHO Anthro software and classiﬁed following the WHO criteria
and Frisancho references for MUACp, TSTp and MAMCp. Phase angle (PhA) and
body cell mass (BCM) were assessed by BIA. Three-day food intake and 24 h recall
(ﬁve-pass) were recorded and analyzed using the “Food Processor” software. The
intervention protocol was based on speciﬁc nutrition recommendations. Fifty-two
children were re-evaluated 3 and 6 months later.
Results: The mean value for Weight–Height z score was −0.04 (±1.65), Height–
age z was −0.37 (±1.19), Weight–age z was −0.22 (±1.39), BMI–age z was
0.07 (±1.32), MUACz was −0.12 (±1.29), TSFz was 0.06 (±1.03). The mean
value of the BMIp was 50.16. The mean PhA values were 4.94 (±0.91). Six
months after the initiation of nutritional intervention, energy intake/total energy
expenditure ratio (median) was signiﬁcantly increased (p = 0.001). Mean values
of Waz, Haz and MUACz were signiﬁcantly improved (p = 0.039, p = 0.020 and
p = 0.004, respectively).
Conclusions: The implementation of a nutritional intervention protocol can improve
further nutrition intake, as well as the overall nutritional status, in a short term
study. Longer implementation and regular follow-up are expected to further improve
outcome.
209 Changes in nutritional status associated with chest exacerbations
in children with cystic ﬁbrosis
C. Smith1, J. English2, K. Chetty3, P. Seddon3. 1Nutrition and Dietetics, Royal
Alexandra Children’s Hospital, Brighton, United Kingdom; 2University of Surrey,
Nutrition and Dietetics, Guildford, United Kingdom; 3Royal Alexandra Children’s
Hospital, Respiratory Medicine, Brighton, United Kingdom
Objectives: We hypothesised a negative impact during IV antibiotic treatments
(IVs) on nutritional status.
Method:We identiﬁed patients’ (Pts) most recent IVs associated with an acute chest
exacerbation. Weight (wt) and BMI Z scores were reviewed at the start (IVStart)
and at the end of treatment (IVEnd) +/− 1 day. This data was also reviewed for
the 2 routine clinics prior to the IVs episode (Clinic −1 and −2) and the 2 routine
subsequent clinics (Clinic +1 and Clinic +2). Routine clinics occur 3-monthly,
therefore the period from Clinic −2 to +2 represents a 9-month period centred
around the exacerbation. Pts with any incomplete data were excluded.
Results: 17 pts (11 females, 6 males), median age 9 yrs 7 months were identiﬁed.
Wt improved during IVs in 14/17 pts. Across all pts there was a signiﬁcant change
in wt of +0.8 kg (p< 0.01) and BMI Z score +0.4 SD (p< 0.01). Mean duration of
IVs was 2.4 weeks (range 2−4 weeks), average gain of + 0.37 kg/wk. Only 2 of
the pts received their IVs exclusively as in-pts. Only 2 pts were in-pts for the full
IV course and these patients were both in the top quartile for weight gain. There
were non-signiﬁcant trends for BMI Z-score to decrease both prior to and after the
IVs (Clinic −1 to IVStart: −0.23 SD; IVEnd to Clinic+1: −0.17 SD) and over the
9 month period containing the exacerbation (Clinic −2 to Clinic +2: −0.15 SD).
Conclusion: Nutritional status improved during IVs for exacerbations. Status tended
to falter both before and (more surprisingly) after IV courses. Our results require
conﬁrmation in a larger cohort, but suggest targeted intensive nutritional support
not only during but following treatment of an exacerbation.
210 Changes in the nutritional status and dietary intake of adults with
cystic ﬁbrosis since 1997
S.J. King1,2, Z. Sekuloska2, R. Gallo2, I. Swan1, Z. Al-Helou2, J.W. Wilson3,
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Objectives: To evaluate the nutritional status and dietary intake of an adult outpatient
CF population and compare with a similar study conducted in 1997 [1].
Methods: Non-transplanted stable adults with CF were eligible if they had not
received intravenous antibiotics in the previous 4 weeks. Height, weight, 4 skinfold
thicknesses and mid-arm circumference (MAC) were measured. BMI and %body fat
were calculated. Seven-day food diaries were completed. Unpaired t-tests were used to
compare results with the 1997 study [1].
Results: 59 patients participated (mean±SD age 31.0±9.2 y; mean FEV1%
67.3±23.7%). Compared with 1997, more patients had a BMI <20 kg/m2 (14% vs
9%), and more had a BMI >25 kg/m2 (17% vs 9%). Mean BMI in males increased
since 1997. MAC and %fat showed a trend to increase. All parameters were unchanged
in females. Energy intake was unchanged in both genders however %energy from fat
decreased since 1997 (31% vs 35%, p = 0.01).
Table: 1997 vs 2012−13 comparison
Males Females
1997 2012−13 p 1997 2012−13 p
n [n for dietary intake] 24 [22] 29 [11] 19 [16] 30 [13]
BMI (kg/m2) 22.8 (2.8) 23.4 (3.1) <0.001 22.4 (2.5) 21.6 (2.0) 0.22
% body fat 14.4 (5.4) 17.2 (5.4) 0.06 28.0 (5.2) 27.8 (4.2) 0.88
MAC (cm) 27.9 (3.8) 29.9 (3.9) 0.07 26.1 (2.9) 26.1 (2.0) 1.0
Energy intake (MJ) 12.6 (3.1) 12.0 (3.4) 0.93 9.6 (2.9) 9.2 (2.4) 0.69
Fat intake (g) 122 (37) 99 (28) 0.08 92 (30) 82 (30) 0.38
Data are mean (SD).
Conclusions: The nutritional status of CF males has improved since 1997; while
females have plateaued. The stability of energy intake suggests other reasons for
increased BMI in males. Gender differences in body image and weight preferences
might contribute to our ﬁndings and need to be explored, as do food preferences given
the reduction in fat intake.
Reference(s)
[1] Richardson I et al (2000). Nutrition 16: 255−9.
211 Overweight and obesity in the cystic ﬁbrosis Israeli national
center
B. Kochavi1. 1Sheba Medical Center, National CF Center, Ramat Gan, Israel
The median life expectancy of Cystic Fibrosis (CF) has increased to above 40 years
old. Currently we observed more and more CF patients with overweight and obesity.
The objectives of this study were to describe the prevalence of overweight and
obesity in the Israeli national center and to evaluate the relation between higher
body mass index (BMI) and age, lung function, genotype, cystic ﬁbrosis related
diabetes (CFRD), pancreatic function and lipid proﬁle.
Methods: We identiﬁed 17 CF patients (aged 10−54) at risk for overweight and
obesity from 158 patients in the CF Israeli national center. Younger patients with
a BMI over the 85th but less than the 95th percentile were considered overweight
and patients with BMI greater than the 95th percentile were considered obese. BMI
values greater than 25 and 30 kg/m2 respectively deﬁne overweight and obesity in
adults. Age, lung function, genotype, CFRD, pancreatic function as well as lipid
proﬁle were evaluated.
Results: Of the 158 CF patients aged 10−54, 17 patients (11%) were overweight
or obese. 8% were overweight and 3% were obese. Of these patients 8 (47%)
were pancreatic insufﬁciency (PI) and 9 (53%) were pancreatic sufﬁciency (PS).
4 (23.5%) were obese and PS with mean FEV1 of 95 percent predicted. In PI
patients higher BMI is associated with CFRD. Overweight PI subjects were older
and had milder genotypes. Lipid concentrations were not related to BMI.
Conclusions: Overweight and obesity in our CF center is increasing. The adult and
pediatric CF guidelines on nutrition focus on high fat high calorie CF diet with no
recommendations in the CF patients who are overweight or obese.
